Shaanxi Meibang Pharmaceutical Group Co Ltd (605033) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.246x

Based on the latest financial reports, Shaanxi Meibang Pharmaceutical Group Co Ltd (605033) has a cash flow conversion efficiency ratio of 0.246x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥281.88 Million ≈ $41.25 Million USD) by net assets (CN¥1.15 Billion ≈ $167.89 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Shaanxi Meibang Pharmaceutical Group Co defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.

Shaanxi Meibang Pharmaceutical Group Co Ltd - Cash Flow Conversion Efficiency Trend (2017–2024)

This chart illustrates how Shaanxi Meibang Pharmaceutical Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Shaanxi Meibang Pharmaceutical Group Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shaanxi Meibang Pharmaceutical Group Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Bsm Chemical Co Ltd SHE:300796	0.056x
Gladstone Investment Corporation 8.00% Notes due 2028 NASDAQ:GAINL	0.013x
Acme Electronics TWO:8121	0.015x
Chongqing Sansheng Building Materials Co Ltd SHE:002742	0.019x
Xinjiang Tianrun Dairy Co Ltd SHG:600419	0.071x
Greenyard NV BR:GREEN	0.189x
Primis Financial Corp NASDAQ:FRST	-0.127x
Columbus McKinnon Corporation NASDAQ:CMCO	-0.115x

Annual Cash Flow Conversion Efficiency for Shaanxi Meibang Pharmaceutical Group Co Ltd (2017–2024)

The table below shows the annual cash flow conversion efficiency of Shaanxi Meibang Pharmaceutical Group Co Ltd from 2017 to 2024. For the full company profile with market capitalisation and key ratios, see how much is Shaanxi Meibang Pharmaceutical Group Co worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥1.12 Billion ≈ $164.57 Million	CN¥280.40 Million ≈ $41.03 Million	0.249x	-17.03%
2023-12-31	CN¥1.11 Billion ≈ $163.04 Million	CN¥334.79 Million ≈ $48.99 Million	0.300x	+158.23%
2022-12-31	CN¥1.09 Billion ≈ $158.97 Million	CN¥126.41 Million ≈ $18.50 Million	0.116x	+203.46%
2021-12-31	CN¥966.95 Million ≈ $141.50 Million	CN¥-108.75 Million ≈ $-15.91 Million	-0.112x	-167.50%
2020-12-31	CN¥449.37 Million ≈ $65.76 Million	CN¥74.88 Million ≈ $10.96 Million	0.167x	-51.92%
2019-12-31	CN¥370.63 Million ≈ $54.24 Million	CN¥128.45 Million ≈ $18.80 Million	0.347x	+464.79%
2018-12-31	CN¥276.37 Million ≈ $40.44 Million	CN¥16.96 Million ≈ $2.48 Million	0.061x	-62.35%
2017-12-31	CN¥180.43 Million ≈ $26.40 Million	CN¥29.41 Million ≈ $4.30 Million	0.163x	--

About Shaanxi Meibang Pharmaceutical Group Co Ltd

SHG:605033 China Agricultural Inputs

Market Cap

$358.29 Million

CN¥2.45 Billion CNY

Market Cap Rank

#14064 Global

#4209 in China

Share Price

CN¥18.11

Change (1 day)

-0.60%

52-Week Range

CN¥18.11 - CN¥31.54

All Time High

CN¥31.54